Unknown

Dataset Information

0

The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy.

ABSTRACT:

SUBMITTER: Li D 

PROVIDER: S-EPMC9047232 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders.
| S-EPMC8669852 | biostudies-literature
Unknown SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy.
| S-EPMC8514341 | biostudies-literature
Unknown T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease.
| S-EPMC8385945 | biostudies-literature
Unknown Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies
| S-SCDT-10_1038-S44318-024-00061-0 | biostudies-other
Unknown SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.
| S-EPMC8344527 | biostudies-literature
Unknown Anti-TNF-? Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease.
| S-EPMC6282128 | biostudies-literature
Unknown Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases.
| S-EPMC5113857 | biostudies-literature
Unknown Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease.
| S-EPMC6413341 | biostudies-literature
Unknown Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.
| S-EPMC7247673 | biostudies-literature
Transcriptomics Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease
2022-07-26 | GSE191331 | GEO